TheStreet Ratings

10 Best Life Sciences Stocks for 2016 - Top Stocks - TheStreet Ratings

Top Rated Stocks

Every day TheStreet Ratings produces a list of the top rated stocks. These 10 life sciences stocks are rated highest by our methodology.

Equity Top: Life Sciences Tools & Services


Source: TheStreet Ratings

Best Investments for

Life Sciences

The Danish pharmaceuticals maker is facing tighter margins and tougher competition in the U.S.
9/29/16 6:53AM
Cramers is avoiding Nike and loves Newell so much he bought the company for Action Alerts PLUS.
9/29/16 6:00AM
The "placebo ate my clinical trial" excuse doesn't make sense, which places Intra-Cellular's plan to seek marketing approval for its schizophrenia drug in serious jeopardy.
9/29/16 5:52AM
The stocks we thought would be the strongest in 2016 are now losing their footing, Cramer says.
9/28/16 8:11PM
Here's a technical look at how to trade some of the most active stocks on the market right now.
9/28/16 2:50PM
As consumer confidence and health care spending soar, Johnson & Johnson is becoming one of the best total return packages available.
9/28/16 1:13PM
Origin Agritech (SEED) said late Tuesday it was selling its commercial seed production and distribution business for $60 million to Beijing Shihui Agricultural Development.
9/28/16 12:47PM
Biotech stocks are struggling this year, but investors should not throw in the towel on Amgen, Gilead, bluebird and Bellicum
9/28/16 12:25PM
This pharmaceutical giant has struggled in recent years but is wisely repositioning itself as the world's largest manufacturer of vaccines.
9/28/16 9:55AM
Here is a look at two big pharma stalwarts to determine the better stock to buy for growth and income.
9/28/16 9:29AM
Analysts are predicting that the legal pot market could reach $6.7 billion in sales this year.
9/28/16 9:13AM
A series of clinical trials will test the combination of Bristol-Myers Squibb's Opdivo with Nektar's NKTR-214 in multiple tumor types.
9/27/16 7:00AM
Historically, September is a challenging month for stock market investors, but it ushers in a season that's typically paired with strong market performance.
9/27/16 6:36AM
Amgen's effort to improve disappointing sales of its multiple myeloma drug Kyprolis took a hit Tuesday with the failure of a phase III clinical trial involving newly diagnosed patients.
9/27/16 6:27AM
Debate switches futures into positive territory after down day on Wall Street.
9/26/16 10:58PM